Tower Research Capital (TRC)’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Tower Research Capital (TRC)’s Portfolio TLC Stock Details TLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$1K	–	5270
2020 Q2	$1K	Buy	+100	New	+$483	﹤0.01%	4684

Other funds holding TLC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Howe & Rusling Rochester, New York $1.53B AUM 21.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tower Research Capital (TRC)'s TLC Position: Q3 2020 in Review

Tower Research Capital (TRC) sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q3 2020, closing a stake of 100 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in TLC in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 5 funds tracked by Wall St. Rank hold TLC as of Q3 2020.

Tower Research Capital (TRC) reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q3 2020 after selling out during the quarter.
Tower Research Capital (TRC) sold 100 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q3 2020, an estimated $1K.
Tower Research Capital (TRC) first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q2 2020 and held it in 1 quarter.
Tower Research Capital (TRC)'s Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $1K in Q2 2020.
5 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q3 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.